Noticias de HIMS_US

Mercado

Noticias del mercado

Últimas noticias sobre HIMS_US — 694 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: HIMS_US 694 resultados
03/09/2026 HIMS_US — newmediawire.com
Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Before Lead Plaintiff Deadline on November 2, 2026

NEW YORK, NY - September 3, 2026 (NEWMEDIAWIRE) - Kaplan Fox (2) the Company charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is “right for them;” (3) the foregoing conduct subjected the Company to regulatory scrutiny; (4) as a result of the foregoing, the Company was reasonably likely to incur fees and penalties; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. WHY CONTACT KAPLAN FOX? Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nat…

03/09/2026 HIMS_US — PR Newswire
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS

/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC

03/09/2026 HIMS_US — NewMediaWire
Kaplan Fox Reminds Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to a Securities Class Action Deadline - Contact the Firm Before November 2, 2026

NEW YORK, NY - September 3, 2026 (NEWMEDIAWIRE) - Kaplan Fox (2) the Company charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is “right for them;” (3) the foregoing conduct subjected the Company to regulatory scrutiny; (4) as a result of the foregoing, the Company was reasonably likely to incur fees and penalties; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. WHY CONTACT KAPLAN FOX? Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nat…

03/09/2026 HIMS_US — FinancialContent
Hims & Hers Health, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – HIMS

The DJS Law Group reminds investors of a class action lawsuit against Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

03/09/2026 HIMS_US — PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hims & Hers Health, Inc. - HIMS

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS). Such investors...

02/09/2026 HIMS_US — law360.com
Hims & Hers Investor Sues Over FTC Privacy, Billing Claims

Telehealth company Hims & Hers Health Inc. was hit with a proposed securities class action accusing it of inflating its share prices by failing to disclose certain practices that led to a suit by the Federal Trade Commission accusing it of sharing customers' sensitive health information with big tech companies and using deceptive billing methods.

02/09/2026 HIMS_US — NewMediaWire ES ← EN
Kaplan Fox anima a los inversores de Hims & Hers Health, Inc. (NYSE: HIMS) a ponerse en contacto con la empresa para conocer sus derechos legales

NEW YORK, NY - September 2, 2026 (NEWMEDIAWIRE) - Kaplan Fox (2) the Company charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is “right for them;” (3) the foregoing conduct subjected the Company to regulatory scrutiny; (4) as a result of the foregoing, the Company was reasonably likely to incur fees and penalties; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. WHY CONTACT KAPLAN FOX? Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nat…

02/09/2026 HIMS_US — PR Newswire
HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Hims & Hers Class Action Lawsuit

/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4,...

02/09/2026 HIMS_US — The National Law Review ES ← EN
Hims & Hers Health (NYSE: HIMS) se enfrenta a una demanda colectiva sobre valores

Hims & Hers Health, Inc. (HIMS) Securities Class Action

Página 2 de 35